Current precision of immunological extracorporeal plasma treatment

Transfusion and Apheresis Science

Volumn 24, Issue 1, 2001, Pages 39-47

  Nydegger, Urs E ^a   Rieben, Robert ^a   Mohacsi, Paul ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; IMMUNOGLOBULIN; PROTEIN A; VON WILLEBRAND FACTOR;

APHERESIS; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HUMAN; IMMUNOADSORPTION; INFLAMMATION; PLASMAPHERESIS;

BLOOD COMPONENT REMOVAL; HUMANS; IMMUNOSORBENT TECHNIQUES; PLASMA; SPECIMEN HANDLING;

EID: 0035168806     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(00)00129-6     Document Type: Conference Paper

References (49)

1. Blood irradiation for intraoperative autotransfusion in cancer surgery. Demonstration of efficient elimination of contaminating tumor cells
2. Therapeutic monoclonal antibodies
3. The ubiquitin proteasome pathway and pathogenesis of human diseases
4. The contact system: a proinflammatory pathway with antithrombotic activity
5. Inhibition by immunoglobulins of S. aureus adherence to fibronectin-coated foreign surfaces
6. Which glyocosaminoglycans are suitable for antithrombogenic or athrombogenic coatings of biomaterials? Part II: covalently immobilized endothelial cell surface heparan sulfate (ESHS) and heparin (HE) on synthetic polymers and results of antimal experiments
7. An idiotope-anti-idiotope complex and the structural basis of molecular mimicking
8. Natural autoantibodies: from horror autotoxicus to gnothi se-auton
9. Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease
10. Morphological features in IgA nephropathy
11. Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element
12. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature
13. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproeinasee (MT1-MMP) derived fibrin(ogen) fragments D-dimer and d-like monomer: NH2-terminal sequences of late-stage digest fragments
14. Post-transplantation cytotoxic immunoglobulin G is associated with a high rate of acute allograft dysfunctions in heart transplant recipients
15. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model
16. Die Eiweissüberempfindlichkeit gewebsanaphylaxie
17. A role for hepatitis C virus infection in type II cryoglobulinemia
18. The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection
19. Regulation by complement of acquired immunity
20. Studies of group B streptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
21. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction
22. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal
23. Circulating immune complexes in the serum in SLE and carriers of the hepatitis B antigen: quantitation by binding to radiolabeled C1q
24. Normal levels of allo-but increased levels of potentially autoreactive antibodies against ABO histo-blood group antigens in AIDS patients
25. Modulation of complement-mediated immune damage by intravenous immunoglobulin
26. Use of intravenous immunoglobulins in haematological disorders
27. Adverse effects of intravenous immunoglobulin therapy
28. Circulating tumor necrosis factor α and soluble TNF-α receptors in patients with Guillain-Barré syndrome
29. Balancing (Yin-Yang) hypothesis for assessment of effective apheresis therapies
30. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation
31. Evaluation of serum immunoglobulins by protein electrophoresis and rate nephelometry before and after therapeutic plasma exchange
32. Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents
33. Thrombocytopenia due to enhanced platelet destruction by nonimmunologic mechanisms
34. Thrombotic microangiopathies associated with drugs and bone marrow transplantation
35. Biochemistry and genetics of von Willebrand factor
36. Acquired deficiency of von Willebrand Factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura
37. Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoadsorption
38. Factor H and disease: a complement regulator affects vital body functions
39. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities